LOGIN  |  REGISTER

Recent Insider Transactions - Lyra Therapeutics (NASDAQ: LYRA)

Follow NASDAQ:LYRA Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ LYRA Lyra Therapeutics
Palasis Maria / director, officer: President & CEO
03/18/2024
Buy
$5.77
500,000
$2.885M
500,000
NASDAQ LYRA Lyra Therapeutics
Bishop John E / officer: Chief Technology Officer
01/30/2024
Buy
$4.58
200,000
$916K
200,000
NASDAQ LYRA Lyra Therapeutics
Nieman Richard / officer: Chief Medical Officer
01/30/2024
Buy
$4.58
200,000
$916K
200,000
NASDAQ LYRA Lyra Therapeutics
Cavalier Jason / officer: Chief Financial Officer
01/30/2024
Buy
$4.58
200,000
$916K
200,000
NASDAQ LYRA Lyra Therapeutics
Waksal Harlan / director, officer: Executive Chair
11/10/2023
Buy
$2.96
25,000
$74K
261,966
NASDAQ LYRA Lyra Therapeutics
Palasis Maria / director, officer: President & CEO
06/15/2023
Buy
$2.99
150,000
$449K
150,000
NASDAQ LYRA Lyra Therapeutics
TOBIN JAMES R / director
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
Smith W Bradford / director
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
Poukalov Konstantin / director
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
ALTMAN MICHAEL SETH / director
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
MERRIFIELD C ANN / director
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
snyderman nancy lynn MD / director
06/30/2023
Buy
$4.11
20,000
$82K
20,000
NASDAQ LYRA Lyra Therapeutics
Palasis Maria / director, officer: President & CEO
06/15/2023
Buy
$2.99
150,000
$449K
150,000
NASDAQ LYRA Lyra Therapeutics
NBVM GP, LLC / 10 percent owner
05/31/2023
Buy
$2.43
1.20M
$2.925M
2.52M
NASDAQ LYRA Lyra Therapeutics
NBVM GP, LLC / 10 percent owner
05/31/2023
Buy
$2.43
403,858
$981K
2.26M
NASDAQ LYRA Lyra Therapeutics
NBVM GP, LLC / 10 percent owner
05/31/2023
Buy
$2.43
197,946
$481K
1.11M
NASDAQ LYRA Lyra Therapeutics
NBVM GP, LLC / 10 percent owner
05/31/2023
Buy
$2.67
601,806
$1.609M
601,806
NASDAQ LYRA Lyra Therapeutics
NBVM GP, LLC / 10 percent owner
05/31/2023
Buy
$2.67
201,929
$540K
201,929
NASDAQ LYRA Lyra Therapeutics
NBVM GP, LLC / 10 percent owner
05/31/2023
Buy
$2.67
98,973
$265K
98,973
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
05/31/2023
Buy
$2.43
1.20M
$2.925M
2.52M
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
05/31/2023
Buy
$2.43
403,858
$981K
2.26M
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
05/31/2023
Buy
$2.43
197,946
$481K
1.11M
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
05/31/2023
Buy
$2.67
601,806
$1.609M
601,806
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
05/31/2023
Buy
$2.67
201,929
$540K
201,929
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
05/31/2023
Buy
$2.67
98,973
$265K
98,973
NASDAQ LYRA Lyra Therapeutics
PERCEPTIVE ADVISORS LLC / director, 10 percent owner:
05/31/2023
Buy
$2.49
3.61M
$9.000M
11.47M
NASDAQ LYRA Lyra Therapeutics
PERCEPTIVE ADVISORS LLC / director, 10 percent owner:
05/31/2023
Buy
$2.67
1.81M
$4.826M
1.81M
NASDAQ LYRA Lyra Therapeutics
Bishop John E / officer: Chief Technology Officer
02/27/2023
Buy
$2.31
220,000
$508K
220,000
NASDAQ LYRA Lyra Therapeutics
Richard Robert E. / officer: SVP, Technical Operations
01/31/2023
Buy
$2.85
45,000
$128K
45,000
NASDAQ LYRA Lyra Therapeutics
Waksal Harlan / director, officer: Executive Chair
01/31/2023
Buy
$2.85
200,000
$570K
200,000
NASDAQ LYRA Lyra Therapeutics
Noyes Corinne / officer: See Remarks
01/31/2023
Buy
$2.85
55,000
$157K
55,000
NASDAQ LYRA Lyra Therapeutics
Cavalier Jason / officer: Chief Financial Officer
01/31/2023
Buy
$2.85
140,000
$399K
140,000
NASDAQ LYRA Lyra Therapeutics
Palasis Maria / director, officer: President & CEO
01/31/2023
Buy
$2.85
250,000
$713K
250,000
NASDAQ LYRA Lyra Therapeutics
Nieman Richard / officer: Chief Medical Officer
01/31/2023
Buy
$2.85
55,537
$158K
55,537
NASDAQ LYRA Lyra Therapeutics
MERRIFIELD C ANN / director
06/16/2022
Buy
$5.09
7,250
$37K
7,250
NASDAQ LYRA Lyra Therapeutics
ALTMAN MICHAEL SETH / director
06/16/2022
Buy
$5.09
7,250
$37K
7,250
NASDAQ LYRA Lyra Therapeutics
Smith W Bradford / director
06/16/2022
Buy
$5.09
7,250
$37K
7,250
NASDAQ LYRA Lyra Therapeutics
Waksal Harlan / director, officer: Executive Chair
06/16/2022
Buy
$5.09
953,002
$4.851M
953,002
NASDAQ LYRA Lyra Therapeutics
ANDERSON EDWARD T / director, 10 percent owner:
06/16/2022
Buy
$5.09
7,250
$37K
7,250
NASDAQ LYRA Lyra Therapeutics
snyderman nancy lynn MD / director
06/16/2022
Buy
$5.09
7,250
$37K
7,250
NASDAQ LYRA Lyra Therapeutics
MERRIFIELD C ANN / director:
06/10/2022
Buy
$5.05
4,000
$20K
11,328
NASDAQ LYRA Lyra Therapeutics
MERRIFIELD C ANN / director:
05/13/2022
Buy
$5.00
328
$2K
7,328
NASDAQ LYRA Lyra Therapeutics
MERRIFIELD C ANN / director
05/13/2022
Buy
$4.81
3,500
$17K
7,000

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous